BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CoEHAR - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CoEHAR
X-ORIGINAL-URL:https://www.coehar.org
X-WR-CALDESC:Events for CoEHAR
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230919
DTEND;VALUE=DATE:20230920
DTSTAMP:20260423T230926
CREATED:20230905T182421Z
LAST-MODIFIED:20230905T182458Z
UID:12613-1695081600-1695167999@www.coehar.org
SUMMARY:Between risk\, prevention\, diagnosis\, and therapies for dyslipidemias
DESCRIPTION:High cholesterol is one of the leading risk factors for cardiovascular disease\, as evidenced by multiple epidemiological and intervention studies that have shown a near-linear relationship between this dyslipidemia\, morbidity\, and cardiovascular mortality. \nAfter the forced break due to the SARS-CoV-2 pandemic\, it is appropriate to return to discussing “non-communicable chronic diseases” whose health risks have continued to accumulate in the last 3 years. \nThe conference aims to bring attention to the diagnosis and management of hypercholesterolemia in light of the latest guidelines produced by the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). \nInnovative topics such as environmental risk factors\, including smoking and their role in the progression of atherosclerosis\, will be addressed. Diagnostic ultrasound for patients with hypercholesterolemia (with a particular focus on carotid Doppler) and innovative pharmacological approaches that include PCSK9 inhibitors and bempedoic acid\, drugs that have made new intervention possibilities possible in patients at high and very high cardiovascular risk\, will be discussed. Hypercholesterolemia familial\, a hereditary disease in which a genetic alteration causes extremely high levels of LDL cholesterol that correlate with the high risk of cardiac events in carriers\, will also be discussed. \nThe final session proposes non-pharmacological suggestions for the management of cardiovascular risk\, including lifestyle\, physical activity\, nutraceuticals\, and nutrition\, and in particular\, the Mediterranean diet as a lifestyle that originates in our territory that should be adopted and exported\, physical activity that brings us back in contact with the environment and also has an ecological meaning\, and the potential role of nutraceuticals.
URL:https://www.coehar.org/event/between-risk-prevention-diagnosis-and-therapies-for-dyslipidemias/
LOCATION:Bari\, Bari\, Italy
ATTACH;FMTTYPE=image/webp:https://www.coehar.org/wp-content/uploads/2023/09/Schermata-2023-09-05-alle-11.24.51.png.webp
END:VEVENT
END:VCALENDAR